GB0519294D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- GB0519294D0 GB0519294D0 GB0519294A GB0519294A GB0519294D0 GB 0519294 D0 GB0519294 D0 GB 0519294D0 GB 0519294 A GB0519294 A GB 0519294A GB 0519294 A GB0519294 A GB 0519294A GB 0519294 D0 GB0519294 D0 GB 0519294D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0519294A GB0519294D0 (en) | 2005-09-21 | 2005-09-21 | Compounds |
| PCT/EP2006/009184 WO2007039125A2 (fr) | 2005-09-21 | 2006-09-21 | Composes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0519294A GB0519294D0 (en) | 2005-09-21 | 2005-09-21 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0519294D0 true GB0519294D0 (en) | 2005-11-02 |
Family
ID=35335228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0519294A Ceased GB0519294D0 (en) | 2005-09-21 | 2005-09-21 | Compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0519294D0 (fr) |
| WO (1) | WO2007039125A2 (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2007283113A1 (en) | 2006-08-08 | 2008-02-14 | Sanofi-Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use |
| US11241420B2 (en) | 2007-04-11 | 2022-02-08 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| US20160331729A9 (en) | 2007-04-11 | 2016-11-17 | Omeros Corporation | Compositions and methods for prophylaxis and treatment of addictions |
| UY31968A (es) | 2008-07-09 | 2010-01-29 | Sanofi Aventis | Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos |
| WO2010068601A1 (fr) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant |
| BR112012003973A2 (pt) | 2009-08-26 | 2015-09-08 | Sanofi Sa | hidratos de fluoroglicosídeo heteroaromático cristalinos, produtos farmacêuticos compreendendo estes compostos e seu uso |
| WO2012120053A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation |
| WO2012120052A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation |
| US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
| WO2012120056A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
| EP2683705B1 (fr) | 2011-03-08 | 2015-04-22 | Sanofi | Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG72827A1 (en) * | 1997-06-23 | 2000-05-23 | Hoffmann La Roche | Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives |
| GB9927056D0 (en) * | 1999-11-17 | 2000-01-12 | Karobio Ab | Thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| GB0406378D0 (en) * | 2004-03-22 | 2004-04-21 | Karobio Ab | Novel pharmaceutical compositions |
| GB0406380D0 (en) * | 2004-03-22 | 2004-04-21 | Karobio Ab | Novel pharmaceutical compositions |
-
2005
- 2005-09-21 GB GB0519294A patent/GB0519294D0/en not_active Ceased
-
2006
- 2006-09-21 WO PCT/EP2006/009184 patent/WO2007039125A2/fr not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007039125A2 (fr) | 2007-04-12 |
| WO2007039125A3 (fr) | 2007-06-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0508472D0 (en) | Compounds | |
| GB0503962D0 (en) | Compounds | |
| GB0507602D0 (en) | Compounds | |
| GB0502418D0 (en) | Compounds | |
| GB0502316D0 (en) | Compounds | |
| GB0508463D0 (en) | Compounds | |
| GB0502299D0 (en) | Compounds | |
| GB0502310D0 (en) | Compounds | |
| GB0505084D0 (en) | Compounds | |
| GB0519294D0 (en) | Compounds | |
| GB0503961D0 (en) | Compounds | |
| AP2007004220A0 (en) | Motilide compounds | |
| GB0505086D0 (en) | Compounds | |
| GB0506467D0 (en) | Compounds | |
| EP1907385A4 (fr) | Composes | |
| GB0505509D0 (en) | Compounds | |
| GB0508460D0 (en) | Compounds | |
| GB0505735D0 (en) | Compounds | |
| GB0503145D0 (en) | Compounds | |
| GB0501985D0 (en) | Compounds | |
| GB0501984D0 (en) | Compounds | |
| GB0505085D0 (en) | Compounds | |
| EP1867650A4 (fr) | Composes de l hydroxymethylbore | |
| GB0501857D0 (en) | Compounds | |
| GB0502092D0 (en) | Compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |